RESULTS: Our findings reveal that PGC-1β silencing sensitizes ovarian cancer cells to PARPi by impairing oxidative metabolism, reducing succinate levels and decreasing Fen1 succinylation and SUMOylation. Here, PPARGC1B is linked to ovarian carcinoma.